ALDOSOMNIL 1MG TABLETS

Valsts: Kipra

Valoda: grieķu

Klimata pārmaiņas: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

Aktīvā sastāvdaļa:

LORMETAZEPAM

Pieejams no:

LABORATORIO ALDO-UNION S.L. (0000003460) BARONESA DE MALDA 73, ESPLUGUES DE LOBREGAT, ESPLUGUES DE LOBREGAT (BARCELONA), 08950

ATĶ kods:

N05CD06

SNN (starptautisko nepatentēto nosaukumu):

LORMETAZEPAM

Deva:

1MG

Zāļu forma:

TABLETS

Kompozīcija:

LORMETAZEPAM (0000848759) 1MG

Ievadīšanas:

ORAL USE

Receptes veids:

Ειδική άδεια άρθρο 126A

Ārstniecības joma:

LORMETAZEPAM

Produktu pārskats:

Νομικό καθεστώς: Με Ιατρική Συνταγή; PACK WITH 30 TABS IN BLISTER(S) (33S012001) 30 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή

Lietošanas instrukcija

LAB. ALDO-UNIÓN, S.L.
1+1 NEGRO
22 / 03 / 2016
TRAZADA
160 x 270 mm
C. BARRAS:
OFFSET
60 g
9211
67939
ALDOSOMNIL 1mg tablets (LEDPHARMA-CHIPRE)
51374/A-15
51374/B-16
160 x 30 mm
PACKAGE LEAFLET: INFORMATION FOR THE USER
ALDOSOMNIL 1 MG TABLETS
LORMETAZEPAM READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU:
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their symptoms are the same as
yours.
- If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See
section 4.
WHAT TS IN THIS LEAFLET:
1. What ALDOSOMNIL is and what it is used for
2. What you need to know before you take ALDOSOMNIL
3. How to take ALDOSOMNIL
4. Possible side effects
5. How to store ALDOSOMNIL
6. Contents of the pack and other information
1. WHAT ALDOSOMNIL IS AND WHAT IT IS USED FOR
ALDOSOMNIL contains the active substance lormetazepam, which is a
benzodiazepine with anxiolytic, muscle relaxant, sedative
and hypnotic properties.
Doctors prescribe ALDOSOMNIL 1 MG for sleep disorders and for all
forms of insomnia, especially when the patient has
difficulties falling asleep, either initially or atter an early
morning awakening.
In most cases, only short-term treatment with ALDOSOMNIL 1 MG is
needed (treatment should generally not exceed two weeks).
Treatment should be started at the lowest possible dosage. The maximum
dosage should not be exceeded.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ALDOSOMNIL 1 MG TABLETS
DO NOT TAKE ALDOSOMNLL:
- lf you are allergic (hypersensitive) to the active substance, the
benzodiazepine group in general or any of the other ingredients
of ALDOSOMNIL.
- lf you have had sleep-related or other breathing difficulties for
some time.
- lf you have muscle or severe kidney problems.
- lf you have an addicti